Evaluating the efficacy of a new treatment regimen versus standard therapy on the risk of heart failure events and cardiovascular mortality in patients with heart failure and impaired renal function
Evaluating the efficacy of a new treatment regimen versus standard therapy on the risk of heart failure events and cardiovascular mortality in patients with heart failure and impaired renal function